PAI-1 Peptide (bs-1704P)

PAI-1 Peptide

Quantity size:

500ug

Source:

Synthetic Peptide

Form:

lyophilized powde

Purity:

≥95% (Purified by HPLC)

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

Immunology research
Blocking Peptide of The bs-1704R Antibody

Background:

PAI1 (plasminogen activator inhibitor 1) is originally cloned from human endothelial cell (Pannekoek 1986, Ginsburg 1986) and rat hepatoma cell 3 cDNA libraries. As a member of the serpin family of serine protease inhibitors, PAI1 inhibits both tissue type plasminogen activator (tPA) and urokinase type plasminogen activator (uPA). High PAI1 levels are associated with an increased risk of thromboembolic disease while PAI1 deficiency may represent an inherited autosomal recessive bleeding disorder.

Also known as:

plasminogen activator inhibitor 1; ERPINE1; AI; LANH1; PAI-1; AI1; serpin peptidase inhibitor, clade E; nexin, plasminogen activator inhibitor type 1; prebeta-migrating plasminogen activator inhibitor; PAI precursor polypeptide.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.